| Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net loss | -21 | -17 | -7 | -2 | -1 | -2 | -6 | -36 | -45 | -45 | -10 |
|---|
| Depreciation and amortization | - | - | 4 | 4 | 5 | 6 | 7 | 12 | 11 | 12 | 16 |
|---|
| Stock-based compensation expense | 4 | 3 | 3 | 3 | 5 | 7 | 9 | 28 | 33 | 33 | 33 |
|---|
| Goodwill, Impairment Loss | - | - | - | - | - | - | - | - | - | - | 5 |
|---|
| Other, net | - | - | 0 | -0 | -0 | -0 | -0 | 2 | -1 | -1 | 2 |
|---|
| Accounts and other receivables | 0 | 0 | 2 | 10 | 11 | 23 | 43 | 66 | 67 | 35 | 7 |
|---|
| Prepaid expenses and other assets | 0 | 1 | -0 | 0 | 3 | 0 | 3 | 3 | 5 | 2 | -3 |
|---|
| Increase (Decrease) in Accounts Payable | 0 | -0 | 1 | 3 | 5 | 4 | 10 | 9 | 3 | 2 | 2 |
|---|
| Reserve for veterinary invoices | -1 | 1 | 3 | 3 | 3 | 5 | 8 | 11 | 4 | 19 | -11 |
|---|
| Deferred revenue | 1 | 2 | 2 | 9 | 10 | 19 | 40 | 54 | 56 | 33 | 17 |
|---|
| Net cash provided by (used in) operating activities | -11 | -10 | 5 | 10 | 13 | 16 | 22 | 7 | -8 | 19 | 48 |
|---|
| Purchases of investment securities | 35 | 25 | 32 | 32 | 53 | 66 | 65 | 96 | 273 | 166 | 133 |
|---|
| Maturities and sales of investment securities | 29 | 20 | 27 | 23 | 35 | 50 | 44 | 58 | 239 | 190 | 128 |
|---|
| Cash paid in business acquisition, net of cash acquired | - | - | - | - | - | - | - | - | 15 | - | - |
|---|
| Purchases of property, equipment, and internal-use software | 6 | 5 | 2 | 3 | 57 | 5 | 7 | 12 | 17 | 18 | 10 |
|---|
| Other | - | - | - | - | 1 | 3 | -0 | 2 | 2 | -2 | -2 |
|---|
| Net cash provided by (used in) investing activities | -12 | -10 | -7 | -13 | -81 | -28 | -77 | -52 | -68 | 8 | -13 |
|---|
| Payments for Repurchase of Common Stock | - | - | - | - | - | - | - | - | 6 | - | - |
|---|
| Proceeds from Stock Options Exercised | 0 | 1 | 4 | 3 | 4 | 3 | 6 | 4 | 2 | 3 | 1 |
|---|
| Shares withheld to satisfy tax withholding | - | 1 | 1 | 1 | 2 | 2 | 1 | 5 | 4 | 2 | 3 |
|---|
| Proceeds from Debt Financing | - | - | - | - | - | - | 6 | - | 69 | 60 | - |
|---|
| Repayment of debt financing | - | - | - | - | 10 | - | 32 | - | 1 | 2 | 1 |
|---|
| Other | - | - | - | - | 0 | -0 | -0 | - | - | -0 | -1 |
|---|
| Net cash provided by (used in) financing activities | 61 | -14 | 8 | 5 | 71 | 14 | 171 | -1 | 61 | 59 | -4 |
|---|
| Net change in cash, cash equivalents, and restricted cash | - | - | - | - | - | 3 | 116 | -45 | -16 | 86 | 29 |
|---|
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | - | - | - | - | - | - | - | - | -1 | 0 | -2 |
|---|
| Income taxes paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 |
|---|
| Interest paid | - | - | - | - | - | 1 | 1 | 0 | 3 | 12 | 13 |
|---|
| Capital Expenditures Incurred but Not yet Paid | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
|---|